Top

Tag: Antibodies


Clinical Trials, Research and Development

Mucosal Antibodies in Airways Reduce Risk of Omicron Infection

September 16, 2022

Via: GEN

A research team led by scientists from the Karolinska Institute and Danderyd Hospital in Sweden report that high levels of mucosal antibodies in the airways reduce the risk of being infected by omicron. However, many people do not receive detectable […]


FDA, Regulations

Omicron prompts FDA to restrict use of specific antibodies

January 26, 2022

Via: European Pharmaceutical Review

The US Food and Drug Administration (FDA) has revised the authorisations for two monoclonal antibody treatments – bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab and imdevimab). These treatments are highly unlikely to be active against the Omicron variant, according […]


Industry, Vaccines

Next-gen COVID vaccine to make persistent neutralizing antibodies

August 30, 2021

Via: Medical News

Scientists and pharmaceutical companies have successfully generated vaccines to fight the coronavirus disease (COVID-19) pandemic. Most of these vaccines are very effective in combating the disease. However, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA virus that has […]


Industry, Vaccines

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

July 26, 2021

Via: Medical News

The development and emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern that could potentially evade a vaccine-induced immune response is an ongoing concern, with the alpha (B.1.1.7), beta (B.1.351), gamma (B.1.248), and delta (B.1.614.2) lineages having […]


Industry, Vaccines

Durable antibody response at least 8 months following vaccination with J&J COVID vaccine

July 9, 2021

Via: Medical News

A recent study by a team of scientists at Beth Israel Deaconess Medical Center and Janssen Vaccines & Prevention has demonstrated that humoral and cellular immunity elicited by the coronavirus disease 2019 (COVID-19) vaccine Ad26.COV2.S remains active for at least […]


Industry, Vaccines

COVID-19 vaccines are effective in 94% of cancer patients, shows study

July 1, 2021

Via: Medical News

In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited […]


Industry, Vaccines

New study may lead to more effective and powerful COVID-19 vaccines

June 17, 2021

Via: Medical News

A new study looking at the way human cells activate the immune system in response to SARS-CoV-2 infection could open the door to even more effective and powerful vaccines against the coronavirus and its rapidly emerging variants keeping the global […]


Clinical Trials, Research and Development

Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19

February 4, 2021

Via: BioSpace

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced positive preliminary results from its Phase 1 trial of iNKT […]


Clinical Trials, FDA, Regulations, Research and Development

FDA authorizes first test that screens for Covid-neutralizing antibodies

November 6, 2020

Via: CNBC

The Food and Drug Administration announced on Friday that it has authorized the first serology test that screens for neutralizing antibodies caused by a previous coronavirus infection. Neutralizing antibodies prevent viruses from infecting cells, though questions remain about how long […]


Clinical Trials, Research and Development

Eli Lilly and AbCellera Team Up to Develop Coronavirus Antibodies

March 13, 2020

Via: BioSpace

As COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus continues to spread across the globe, Vancouver-based AbCellera and Eli Lilly have teamed up to co-develop antibody products for the treatment and prevention of the virus that was declared a […]